Terms: = Liver cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Staging
12 results:
1. Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Ohama H; Hiraoka A; Tada T; Hirooka M; Kariyama K; Hatanaka T; Tani J; Takaguchi K; Atsukawa M; Itobayashi E; Nishimura T; Tsuji K; Tajiri K; Ishikawa T; Yasuda S; Toyoda H; Fukunishi S; Ogawa C; Kakizaki S; Shimada N; Naganuma A; Kawata K; Kosaka H; Kuroda H; Matono T; Yata Y; Ochi H; Tada F; Nouso K; Morishita A; Itokawa N; Okubo T; Arai T; Tsutsui A; Nagano T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2042. PubMed ID: 38577725
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive prognostic and immunological analysis of Ubiquitin Specific Peptidase 28 in pan-cancers and identification of its role in hepatocellular carcinoma cell lines.
Zhou W; Chen J; Wang J
Aging (Albany NY); 2023 Jul; 15(13):6545-6576. PubMed ID: 37450415
[TBL] [Abstract] [Full Text] [Related]
3. Metastatic malignant melanoma of the breast: report of a case and review of the literature.
Mastoraki A; Gkiala A; Theodoroleas G; Mouchtouri E; Strimpakos A; Papagiannopoulou D; Schizas D
Folia Med (Plovdiv); 2022 Apr; 64(2):354-358. PubMed ID: 35851793
[TBL] [Abstract] [Full Text] [Related]
4. Differences in the presentation and treatment of primary liver tumors at a hepatology center and an oncology center.
Rojas-Pintor KP; Arizmendi-Villarreal MA; Aparicio-Salas JE; Moreno-Peña DP; Hernández-Barajas D; Cordero-Pérez P; Muñoz-Espinosa LE
Rev Gastroenterol Mex (Engl Ed); 2021; 86(4):370-377. PubMed ID: 34384724
[TBL] [Abstract] [Full Text] [Related]
5. [Investigation of Regulatory T Cells and Secreted Immunomodulatory Cytokine IL-10 Levels in Patients with Hepatitis B].
Tuyji Tok Y; Şener AG; Aksoy Gökmen A; Demirdal T; Kaya S
Mikrobiyol Bul; 2020 Apr; 54(2):266-278. PubMed ID: 32723282
[TBL] [Abstract] [Full Text] [Related]
6. Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complex.
Phan C; Zheng Z; Wang J; Wang Q; Hu X; Tang G; Bai H
Biomater Sci; 2019 Nov; 7(11):4758-4768. PubMed ID: 31509117
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological correlation of cancer stem cell markers Oct-4 and CD133 expression as prognostic factor in malignant lesions of gallbladder: An immunohistochemical study.
Fatima N; Srivastava AN; Nigam J; Tandon N; Ahmad R; Kumar V
Indian J Pathol Microbiol; 2019; 62(3):384-390. PubMed ID: 31361225
[TBL] [Abstract] [Full Text] [Related]
8. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.
Duffy AG; Ulahannan SV; Makorova-Rusher O; Rahma O; Wedemeyer H; Pratt D; Davis JL; Hughes MS; Heller T; ElGindi M; Uppala A; Korangy F; Kleiner DE; Figg WD; Venzon D; Steinberg SM; Venkatesan AM; Krishnasamy V; Abi-Jaoudeh N; Levy E; Wood BJ; Greten TF
J Hepatol; 2017 Mar; 66(3):545-551. PubMed ID: 27816492
[TBL] [Abstract] [Full Text] [Related]
9. [Hepatic angiosarcoma: case report and review of literature].
Poggi Machuca L; Ibarra Chirinos O; López Del Aguila J; Villanueva Pflucker M; Camacho Zacarías F; Tagle Arróspide M; Remy Paredes C; Arredondo Manrique G; Scavino Levy Y; Guevara Miranda J
Rev Gastroenterol Peru; 2012; 32(3):317-22. PubMed ID: 23128955
[TBL] [Abstract] [Full Text] [Related]
10. Validation of 8-[123I]iodo-L-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid as an imaging agent for prostate cancer in experimental models of human prostate cancer.
Samnick S; Nestle U; Wagner M; Fozing T; Schaefer A; Menger MD; Kirsch CM
Nucl Med Biol; 2007 Jan; 34(1):99-107. PubMed ID: 17210466
[TBL] [Abstract] [Full Text] [Related]
11. [The clinical significance of E-cadherin and alpha-catenin expression in human gastric cancer].
Dai D; Chen J; Xu H
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):35-8. PubMed ID: 11783066
[TBL] [Abstract] [Full Text] [Related]
12. Pathological study of alpha-chain disease, with special emphasis on evolution.
Galian A; Lecestre MJ; Scotto J; Bognel C; Matuchansky C; Rambaud JC
Cancer; 1977 May; 39(5):2081-101. PubMed ID: 404026
[TBL] [Abstract] [Full Text] [Related]
